Contract analysis

I. Executive Summary You have asked us to analyze whether the proposed settlement of the covenant-enforcement and trade-secret litigation currently pending in the Delaware Court of Chancery — Cascade Retail Holdings Inc. v. Rathore et al., C.A. No. 2025-0198-MTZ — requires disclosure by Cascade Retail Holdings Inc. ("CRH" or the "Company") (Nasdaq: CRHL) under applicable federal securities laws. Specifically, this me

II. Background — Summary of the Litigation and Settlement A. The Underlying Dispute In early February 2025, eight senior merchandising employees of CRH, led by former Senior Vice President of Merchandising Priya Rathore, resigned from the Company in a coordinated departure. Each of the departing employees had occupied senior roles within CRH's merchandising division, which generated approximately $2.3 billion in gros

1. Breach of restrictive covenant agreements (against all eight individual defendants);

2. Breach of confidentiality and non-disclosure obligations (against all eight individual defendants);

3. Misappropriation of trade secrets under the Delaware Uniform Trade Secrets Act, 6 Del. C. § 2001 et seq. ("DUTSA") (against all eight individual defendants and Verdana);

4. Tortious interference with contractual relations (against Verdana); and

5. Civil conspiracy (against all defendants). On March 7, 2025, the Court granted CRH's application for a Temporary Restraining Order ("TRO"), enjoining the individual defendants from using or disclosing CRH's proprietary information and requiring the immediate return of any CRH materials in their possession. In connection with the TRO, CRH was required to post an injunction bond in the amount of $2,500,000, which wa

III. Form 8-K Disclosure Analysis A. Overview of 8-K Reporting Obligations Under the SEC's rules, a registrant is required to file a Current Report on Form 8-K within four (4) business days following the occurrence of specified triggering events enumerated in the form. The purpose of Form 8-K is to ensure that the investing public is promptly informed of material developments affecting the registrant. See Regulation

IV. Form 10-Q Disclosure Analysis (Q1 2025) A. Timing Considerations CRH's fiscal quarter ended on March 31, 2025. As a large accelerated filer, CRH is required to file its Quarterly Report on Form 10-Q within forty (40) days after the end of the fiscal quarter. See Rule 13a-13 under the Securities Exchange Act of 1934; General Instruction A.1 to Form 10-Q. CRH's Q1 2025 Form 10-Q is therefore expected to be filed on

1. Reversal of Litigation Contingency Accrual. The $3,500,000 litigation contingency accrual established in Q1 2025 should be reversed in full, as the settlement outcome is favorable to CRH and no further loss contingency exists.

2. Recognition of Net Settlement Gain. The net gain from the settlement should be recognized. The calculation of the net gain will require coordination with CRH's accounting team and outside auditors, but the preliminary components are as follows: • Total economic recovery: $10,024,500 • Less: Calderwood & Harkness legal fees allocable to the matter (estimated at approximately $1,850,000 through settlement execution)

3. Coordination with Outside Auditors. CRH should promptly engage Hargrove & Tillett CPA, PLLC, CRH's outside independent registered public accounting firm (lead audit partner: Denise Wheatley), to review the proposed accounting treatment and ensure that the subsequent event recognition is appropriately reflected in the Q1 2025 interim financial statements. This coordination should occur as early as practicable — ide

V. Additional Securities Law Considerations A. Regulation FD Regulation FD (17 C.F.R. § 243.100 et seq.) prohibits issuers from selectively disclosing material nonpublic information to certain enumerated categories of recipients — including securities analysts, institutional investment managers, and holders of the issuer's securities — unless the disclosure is made simultaneously to the public (in the case of intenti

VI. Materiality Assessment — Summary Having analyzed the relevant SEC disclosure obligations and accounting standards in the preceding sections, we summarize below our overall materiality assessment of the Settlement Agreement. A. Quantitative Analysis The following table summarizes the quantitative materiality analysis: All quantitative ratios fall well below the typical 5% bright-line threshold that is commonly (th

VII. Recommendations Based on the foregoing analysis, we make the following recommendations:

1. File a Voluntary 8-K Under Item 8.01. CRH should file a voluntary Current Report on Form 8-K under Item 8.01 ("Other Events") promptly following execution of the Settlement Agreement. The target filing date should be on or before April 18, 2025 — within four (4) business days of the April 14, 2025 target execution date — consistent with the ordinary 8-K filing timeline. The Form 8-K should disclose the settlement

2. Update the Q1 2025 Form 10-Q. CRH should update its Q1 2025 Form 10-Q to reflect the settlement as a recognized subsequent event under ASC 855, including the following components: • Financial statement adjustment: reversal of the $3,500,000 litigation contingency accrual and recognition of the net settlement gain, with appropriate footnote disclosure of the subsequent event; • MD&A discussion of the settlement and

3. Coordinate with Hargrove & Tillett CPA, PLLC. CRH should promptly engage its outside independent registered public accounting firm, Hargrove & Tillett CPA, PLLC (lead audit partner: Denise Wheatley), to review the proposed accounting treatment for the settlement, including the subsequent event classification, the reversal of the litigation contingency accrual, and the recognition of the net settlement gain. This c

4. Ensure Insider Trading Restrictions. CRH should confirm that its insider trading policy and any applicable blackout or trading restriction windows cover all CRH personnel with knowledge of the settlement terms — including CEO Marcus Langford, General Counsel Theresa Yun-Park, CPO Roland Ashby, Interim SVP Martin Cho, Audit Committee Chair Dr. Lorraine Stahl, and all other informed directors and officers — through

5. Manage Regulation FD Compliance. CRH should ensure that no selective disclosure of settlement terms occurs to analysts, institutional investors, or other market participants prior to the filing of the Form 8-K. All external communications regarding the settlement should be timed to coincide with or follow the 8-K filing. CRH's investor relations team should be briefed on these requirements and instructed to refer

6. Review Settlement Agreement Confidentiality Provisions. CRH should confirm, in coordination with Verdana's counsel (Morgan Chen, Davis Sunderland LLP), that the confidentiality provisions of the Settlement Agreement include an adequate carve-out for disclosures required or permitted under federal securities laws and the rules of the Nasdaq Stock Market, such that CRH's filing of the Form 8-K and inclusion of settl

VIII. Conclusion For the reasons set forth in this memorandum, we recommend that CRH file a voluntary Current Report on Form 8-K under Item 8.01 promptly following execution of the Settlement Agreement and update its Q1 2025 Form 10-Q to reflect the settlement as a recognized subsequent event under ASC 855, with appropriate narrative disclosures in the MD&A, Legal Proceedings, and (as warranted) Risk Factors sections